Günün Yemeği

Ondokuz Mayıs University (OMU) Faculty of Medicine Neurology Department Faculty Member, Prof. Dr. Murat Terzi, emphasized the significance of machine learning and artificial intelligence (AI) in neurology during an interview with Anadolu Agency (AA) at a medical congress in Antalya.

President of the Turkish Neurology Society, Prof. Dr. Murat Terzi, stated, “AI will be crucial not only in diagnosis, treatment, and decision-making but also in determining the course of diseases. We are conducting significant studies to train AI in the best possible way.”

Prof. Dr. Terzi highlighted ongoing collaborations with engineers to develop AI software and designs to diagnose and provide early treatment for neurological diseases. He noted that AI is equally important for predicting the progression of diseases.

President Terzi: "As a society, we have been conducting serious work for three years."

Detailing the Turkish Neurology Society’s efforts, Prof. Dr. Terzi explained that they have been actively working on AI for three years. He underscored that the AI development process utilizes MRI findings, patient voice data, walking, standing, and speech analysis videos for diagnosing neurological diseases.

“We collaborate with engineers to ensure accurate diagnosis and early treatment,” Terzi noted. “We have been training machines to recognize symptoms of neurological diseases such as Parkinson's, MS, and Alzheimer's.”

Prof. Dr. Terzi pointed out the software and designs already produced in the AI field, highlighting, “We have made significant progress. Our goal is to predict the progression of diseases and apply medication or non-drug treatment methods in the early stages. AI is designed to assist doctors and healthcare professionals rather than replace them in diagnosis and treatment.”

He further mentioned that this year’s courses, workshops, and congresses have specifically included neuroscientists, neurologists, and engineers experienced in AI.

Prof. Dr. Terzi: "We are conducting important studies to train AI effectively."

Emphasizing the importance of foundational knowledge in AI, Terzi stated:

“AI will play a vital role in diagnosis, treatment, decision-making, and determining the course of diseases. We are conducting significant studies to ensure that AI is trained in the best way possible. If not trained correctly, it could lead to misdiagnoses or incorrect treatments. As neuroscientists and neurologists, this is why we will continue prioritizing AI in our future initiatives, just as we have done this year.”

"Neurologists will remain the final decision-makers."

Prof. Dr. Terzi emphasized the importance of uniting neurologists and stakeholders interested in AI research. “If not addressed from the beginning, machine learning and AI can drift into unintended directions and fail to achieve their goals. For this reason, we prioritize AI and incorporate it into all scientific activities as neurologists,” he said.

"AI is a supporting tool in neurology."

Although AI is not yet directly used for diagnosing and treating neurological diseases, Terzi noted that it serves as an auxiliary method in diagnosis, treatment, and disease progression assessment. “AI will continue to play a supportive role, but neurologists and doctors will always remain the final decision-makers,” he emphasized.

Prof. Dr. Terzi concluded by reiterating that machine learning and AI remain top priorities for the Turkish Neurology Society.